XWEL
XWELL, Inc.0.7400
-0.0100-1.33%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
4.27MP/E (TTM)
-Basic EPS (TTM)
-3.34Dividend Yield
0%Recent Filings
8-K
10-Q
8-K
8-K
8-K
XWELL swaps preferred for secured notes
XWELL exchanged Series G preferred stock worth $1.55 million in stated value, plus accrued dividends, for $3.39 million in senior secured convertible notes due in three years and four months, closing around November 5, 2025. The deal slashes conversion prices to $1.00 across notes and amended warrants while securing investor liens on assets, easing cash covenants but mandating a stockholder vote by year-end for full share issuances. This restructures debt yet ties liquidity to a $1.35 million segregated deposit.
APDN
Applied DNA Sciences, Inc.
5.62+1.35
BDSX
Biodesix, Inc.
7.90+0.38
BIAF
bioAffinity Technologies, Inc.
1.38-0.10
CODX
Co-Diagnostics, Inc.
0.25-0.02
DGX
Quest Diagnostics Incorporated
178.66-5.45
IDXG
Interpace Biosciences, Inc.
1.14-0.02
LH
Labcorp Holdings Inc.
258.11-5.22
MDXH
MDxHealth SA
3.36+0.05
PSNL
Personalis, Inc.
7.98-0.50
VRAX
Virax Biolabs Group Limited
0.40-0.01